Full-Time

Global Category Manager

Pharm Sci Large Molecule CMO

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$153.6k - $241.3k/yr

+ Short-term Incentives + Long-term Incentives

Expert

Boston, MA, USA

Category
Procurement & Sourcing
Supply Chain Management
Operations & Logistics
Required Skills
Supply Chain Management
SAP Products
Requirements
  • Bachelor’s degree in supply chain management, Business Administration, Chemistry, Biology, or a related field. Master’s degree preferred.
  • Minimum of 11 years of experience in procurement, category management, or supply chain management, with a focus on pharmaceutical sciences and manufacturing in the pharmaceutical industry.
  • Proven experience in developing and implementing global category strategies within complex and business critical areas.
  • Strong negotiation, contract management, and supplier relationship management skills.
  • Excellent analytical, financial, and strategic thinking abilities.
  • Strong leadership and team management skills.
  • Ability to work effectively in a global, cross-functional environment.
  • Knowledge of industry regulations and quality standards
  • Proficiency in procurement software and tools such as Ariba and SAP.
Responsibilities
  • Develop and implement comprehensive global category strategies for large molecule contract manufacturing and associated raw materials and process development.
  • Conduct market analysis to identify trends, opportunities, and risks.
  • Align category strategies with overall business goals and R&D objectives across functions and regions.
  • Inclusion of ESG (Environmental & Social Governance) objectives in category strategies.
  • Identify, evaluate, and select suppliers.
  • Establish and maintain strong relationships with key suppliers to ensure reliability, quality, and innovation.
  • Negotiate contracts, terms, and conditions with suppliers to achieve optimal pricing and service levels.
  • Lead global sourcing initiatives to drive cost savings and value creation.
  • Implement best practices in procurement processes, including RFIs, RFPs, and RFQs.
  • Ensure compliance with company policies, industry regulations, and quality standards.
  • Develop and manage the annual demand plan with the business for large molecule contract manufacturing.
  • Track and report on cost savings and financial performance of the category.
  • Collaborate with finance teams to forecast and manage spend.
  • Monitor and evaluate supplier performance using key performance indicators (KPIs).
  • Implement continuous improvement initiatives to enhance category performance.
  • Address and resolve any issues related to supplier performance.
  • Mentor and develop a global team of procurement professionals.
  • Provide mentorship, guidance, and training to team members.
  • Foster a culture of collaboration, innovation, and excellence within the team.
Desired Qualifications
  • Preferred ISM (Institute of Supplier Management) Certifications: CPSM® Certified Professional in Supply Management® and CPSD® Certified Professional in Supplier Diversity®.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized in all operations.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene is worth up to $770 million.
  • The company is expanding its market presence in emerging Asian economies.
  • Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

  • Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
  • A data breach incident poses significant cybersecurity and legal risks.
  • The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

ETF Daily News
May 11th, 2025
Tudor Investment Corp ET AL Decreases Stock Holdings in American Well Co. (NYSE:AMWL)

Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.